Ehlers-Danlos Syndrome (Hypermobility Type)

Overview

Plain-Language Overview

Ehlers-Danlos Syndrome (Hypermobility Type) is a genetic condition that affects the body's connective tissues, which provide support to skin, joints, and other organs. This type primarily causes joints to be unusually flexible or loose, leading to frequent joint pain and dislocations. People with this condition often have soft, stretchy skin and may bruise easily. The main health impact is on the musculoskeletal system, causing chronic pain and joint instability. It can also affect daily activities due to joint problems and sometimes leads to early arthritis. The condition varies in severity but generally involves lifelong challenges with joint function and comfort.

Clinical Definition

Ehlers-Danlos Syndrome (Hypermobility Type) is a hereditary connective tissue disorder characterized by generalized joint hypermobility, skin hyperextensibility, and tissue fragility. It is caused by defects in the structure, production, or processing of collagen or collagen-associated proteins, although the exact genetic basis is often unknown. The hallmark feature is joint hypermobility leading to recurrent dislocations, chronic musculoskeletal pain, and early-onset osteoarthritis. Unlike other EDS types, vascular and skin fragility are less prominent. Diagnosis is clinical, based on the presence of Beighton score hypermobility and associated musculoskeletal symptoms. This type is significant due to its impact on quality of life and potential for disabling joint complications.

Inciting Event

Often no specific trigger; symptoms arise from inherent connective tissue defects
Joint injuries or repetitive strain may exacerbate symptoms
Minor trauma can precipitate joint dislocations or soft tissue pain

Latency Period

Symptoms usually present from early childhood but diagnosis may be delayed
Progressive worsening of joint hypermobility and musculoskeletal pain over years
Variable latency between symptom onset and clinical recognition due to subtle early signs

Diagnostic Delay

Symptoms often attributed to benign joint hypermobility or musculoskeletal pain syndromes
Lack of awareness of hypermobility type EDS among clinicians
Overlap with other conditions such as fibromyalgia or chronic pain disorders
Absence of specific laboratory tests leads to reliance on clinical criteria which may be underutilized

Clinical Presentation

Signs & Symptoms

Chronic joint pain and recurrent joint subluxations or dislocations are common presenting complaints.
Fatigue and muscle weakness often accompany joint instability and contribute to functional impairment.
Soft, mildly hyperextensible skin without significant fragility is typical.
Frequent sprains and easy bruising may be reported but are less prominent than in other EDS types.
Autonomic symptoms such as orthostatic intolerance can occur due to associated dysautonomia.

History of Present Illness

Chronic joint pain and recurrent joint subluxations or dislocations without significant trauma
Generalized joint hypermobility with frequent sprains and soft tissue injuries
Skin may be soft, velvety, and mildly hyperextensible without significant scarring
Symptoms often include fatigue and musculoskeletal stiffness worsening with activity
History of easy bruising and delayed wound healing may be reported

Past Medical History

Previous episodes of joint dislocations or sprains with minimal trauma
History of chronic musculoskeletal pain or early-onset osteoarthritis
Prior diagnosis of joint hypermobility syndrome or related connective tissue disorder
No specific prior surgeries or exposures are typically associated

Family History

Autosomal dominant inheritance pattern with multiple affected family members
Relatives with joint hypermobility, chronic pain, or connective tissue abnormalities
Family history of Ehlers-Danlos syndrome or other heritable collagen disorders
Possible history of vascular complications in some family members, though less common in hypermobility type

Physical Exam Findings

Generalized joint hypermobility with a Beighton score ≥5/9 is a hallmark finding in Ehlers-Danlos Syndrome (Hypermobility Type).
Soft, velvety skin that is often mildly hyperextensible but without significant fragility distinguishes this type from other EDS variants.
Muscle hypotonia and poor proprioception may be observed, contributing to joint instability.
Mild skin bruising can be present but is less severe than in classical or vascular EDS types.
Normal scarring without atrophic or widened scars helps differentiate this subtype from classical EDS.

Physical Exam Maneuvers

Beighton score assessment is the primary maneuver to quantify joint hypermobility.
Brighton criteria evaluation combines joint hypermobility with musculoskeletal symptoms to support diagnosis.
Goniometric measurement of joint range of motion helps document hyperextensibility objectively.
Assessment of skin extensibility by gently stretching the skin over the dorsum of the hand or forearm.
Provocative joint stability tests may reveal subluxations or dislocations in frequently affected joints.

Common Comorbidities

Chronic musculoskeletal pain syndrome is frequently associated due to joint instability and overuse.
Temporomandibular joint dysfunction occurs commonly from ligamentous laxity.
Postural orthostatic tachycardia syndrome (POTS) is a recognized comorbidity linked to autonomic dysfunction.
Anxiety and depression are prevalent due to chronic pain and disability.
Functional gastrointestinal disorders such as irritable bowel syndrome may co-occur.

Diagnostic Workup

Diagnostic Criteria

Diagnosis relies on the presence of generalized joint hypermobility assessed by the Beighton score, combined with a history of joint instability and musculoskeletal pain. The 2017 international criteria emphasize major features such as skin hyperextensibility and absence of other EDS subtypes. Family history supports diagnosis but is not always present. Genetic testing is typically not diagnostic due to unknown causative mutations in most cases. Diagnosis is clinical and requires exclusion of other connective tissue disorders.

Pathophysiology

Key Mechanisms

Defective collagen synthesis leading to impaired connective tissue strength and elasticity
Abnormal collagen fibril structure causing joint hypermobility and skin laxity
Dysfunction of extracellular matrix proteins affecting tissue integrity
Increased susceptibility to joint dislocations and soft tissue injuries due to connective tissue fragility

Involvement	Details
Organs	Skin exhibits hyperextensibility and fragility due to defective collagen structure.
	Joints demonstrate hypermobility and recurrent dislocations from weakened connective tissue support.
	Blood vessels can be fragile in vascular Ehlers-Danlos syndrome, predisposing to life-threatening complications.
Tissues	Connective tissue is primarily affected, resulting in skin hyperextensibility, joint laxity, and tissue fragility.
Tissues	Vascular tissue may be involved in some subtypes, increasing risk of arterial rupture and aneurysm.
Cells	Fibroblasts produce defective collagen leading to the characteristic connective tissue fragility in Ehlers-Danlos syndrome.
Cells	Chondrocytes contribute to abnormal cartilage matrix affecting joint stability and function.
Chemical Mediators	Collagen abnormalities, especially in type III and V collagen, underlie the tissue fragility and hyperextensibility.
Chemical Mediators	Matrix metalloproteinases (MMPs) may be dysregulated, contributing to extracellular matrix degradation.

Treatments

Pharmacological Treatments

Analgesics (e.g., acetaminophen, NSAIDs)
- Mechanism:
  - Reduce pain by inhibiting prostaglandin synthesis or central pain pathways.
- Side effects:
  - Gastrointestinal irritation
  - Renal impairment
  - Hepatotoxicity
- Clinical role:
  - First-line
Muscle relaxants
- Mechanism:
  - Decrease muscle spasm and associated pain by central nervous system depression.
- Side effects:
  - Drowsiness
  - Dizziness
  - Dependence
- Clinical role:
  - Adjunctive

Non-pharmacological Treatments

Physical therapy focusing on joint stabilization and strengthening to reduce joint hypermobility and prevent injury.
Use of braces or orthotic devices to support hypermobile joints and prevent dislocations.
Patient education on activity modification to avoid joint overextension and trauma.
Regular cardiovascular monitoring due to potential vascular complications in some Ehlers-Danlos subtypes.

Prevention

Pharmacological Prevention

NSAIDs are used to manage chronic joint pain and inflammation.
Analgesics including acetaminophen may be used for pain control.
Low-dose antidepressants such as amitriptyline can help with chronic pain and associated mood disorders.
Beta-blockers may be prescribed for autonomic symptoms like POTS.
Muscle relaxants can be considered for muscle spasms related to joint instability.

Non-pharmacological Prevention

Physical therapy focusing on joint stabilization and proprioceptive training is essential to prevent dislocations.
Avoidance of high-impact activities reduces risk of joint injury and pain flare-ups.
Use of joint braces or orthotics can provide mechanical support to unstable joints.
Patient education on safe movement techniques and injury prevention is critical.
Regular cardiovascular screening to monitor for rare vascular complications.

Outcome & Complications

Complications

Recurrent joint dislocations and subluxations leading to chronic pain and disability.
Early-onset osteoarthritis from chronic joint instability and cartilage damage.
Chronic musculoskeletal pain syndrome with secondary muscle weakness and deconditioning.
Psychological distress including anxiety and depression due to chronic symptoms.
Rare vascular complications such as easy bruising but major vascular rupture is uncommon in this subtype.

Short-term Sequelae	Long-term Sequelae
Acute joint pain and swelling following subluxations or minor trauma. Transient joint instability episodes causing functional impairment. Muscle spasms and fatigue secondary to joint instability. Bruising after minor injuries due to mild skin fragility. Flare of autonomic symptoms such as dizziness or palpitations during stress or illness.	Chronic joint pain and disability from repeated subluxations and early osteoarthritis. Progressive muscle weakness and atrophy due to disuse and instability. Permanent joint deformities in severe cases of recurrent dislocations. Psychosocial impairment from chronic pain and reduced quality of life. Potential development of chronic fatigue syndrome or fibromyalgia-like symptoms.

Short-term Sequelae

Long-term Sequelae

Acute joint pain and swelling following subluxations or minor trauma.
Transient joint instability episodes causing functional impairment.
Muscle spasms and fatigue secondary to joint instability.
Bruising after minor injuries due to mild skin fragility.
Flare of autonomic symptoms such as dizziness or palpitations during stress or illness.

Chronic joint pain and disability from repeated subluxations and early osteoarthritis.
Progressive muscle weakness and atrophy due to disuse and instability.
Permanent joint deformities in severe cases of recurrent dislocations.
Psychosocial impairment from chronic pain and reduced quality of life.
Potential development of chronic fatigue syndrome or fibromyalgia-like symptoms.

Differential Diagnoses

Ehlers-Danlos Syndrome (Hypermobility Type) versus Marfan Syndrome

Ehlers-Danlos Syndrome (Hypermobility Type)	Marfan Syndrome
Often autosomal dominant but no consistent single gene mutation identified	Autosomal dominant with mutations in FBN1 gene
No ectopia lentis or significant aortic root dilation	Ectopia lentis and aortic root dilation are common
Normal stature with generalized joint hypermobility without typical Marfanoid habitus	Tall stature with arachnodactyly and pectus deformities

Ehlers-Danlos Syndrome (Hypermobility Type) versus Loeys-Dietz Syndrome

Ehlers-Danlos Syndrome (Hypermobility Type)	Loeys-Dietz Syndrome
No specific gene mutation identified; clinical diagnosis	Autosomal dominant with mutations in TGFBR1 or TGFBR2 genes
No significant vascular aneurysms or arterial tortuosity	Arterial tortuosity and aggressive aortic aneurysms
No craniofacial abnormalities	Cleft palate, hypertelorism, and bifid uvula common

Ehlers-Danlos Syndrome (Hypermobility Type) versus Osteogenesis Imperfecta

Ehlers-Danlos Syndrome (Hypermobility Type)	Osteogenesis Imperfecta
Joint hypermobility without bone fragility or fractures	Multiple fractures with bone fragility and blue sclerae
No consistent gene mutation; clinical diagnosis of hypermobility type	Mostly autosomal dominant mutations in COL1A1 or COL1A2
Normal collagen studies	Abnormal collagen type I on biochemical testing

Ehlers-Danlos Syndrome (Hypermobility Type) versus Benign Joint Hypermobility Syndrome

Ehlers-Danlos Syndrome (Hypermobility Type)	Benign Joint Hypermobility Syndrome
Joint hypermobility plus mild skin involvement such as soft, velvety skin	Joint hypermobility with minimal systemic involvement and no skin findings
Diagnosis based on clinical criteria including skin and joint features	No specific diagnostic criteria; diagnosis of exclusion
Possible mild musculoskeletal pain and subluxations	Rare systemic complications

Ehlers-Danlos Syndrome (Hypermobility Type) versus Cutis Laxa

Ehlers-Danlos Syndrome (Hypermobility Type)	Cutis Laxa
Soft, velvety, and hyperextensible skin without sagging	Loose, sagging, inelastic skin with premature aging appearance
Usually autosomal dominant or sporadic with no known mutation	Can be autosomal dominant, recessive, or acquired
No significant pulmonary or hernia complications	Frequent pulmonary emphysema and hernias